SCHEMBL19768063

SCHEMBL19768063

c1cnc2c(-c3ccc(-c4ccc5ccc6ccc(-c7cc8ccccc8c8ccccc78)nc6c5n4)cc3)cccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.43
▸ CCR1 P32246 5/20 0.41
▸ CCR8 P51685 5/20 0.41
▸ CCR5 P51681 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ HIF1A Q16665 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ GMNN O75496 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ MMP2 P08253 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ MMP9 P14780 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ MMP8 P22894 1/20 0.41
▸ THPO P40225 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23370571 0.91 CYP11B1 (0.53) CYP11B1CCR1CCR8CCR5LMNA
SCHEMBL17899293 0.89 CYP11B1 (0.51) CYP11B1CCR1CCR8CCR5LMNA
SCHEMBL19768060 0.88 KDM4E (0.44) CCR1CCR8CCR5LMNACYP3A4
SCHEMBL19768559 0.86 CCR1 (0.55) CCR1CCR8CCR5LMNACYP3A4
SCHEMBL22282048 0.86 CYP11B1 (0.43) CYP11B1CCR1CCR8CCR5LMNA
SCHEMBL19768103 0.85 CYP11B1 (0.43) CYP11B1CCR1CCR8CCR5LMNA
SCHEMBL24475244 0.85 CYP11B1 (0.50) CYP11B1CCR1CCR8CCR5LMNA
SCHEMBL19768056 0.85 CYP11B1 (0.43) CYP11B1CCR1CCR8CCR5LMNA
SCHEMBL23016360 0.85 NPC1 (0.44) CYP11B1CCR1CCR8CCR5LMNA
SCHEMBL17899297 0.85 CYP11B1 (0.50) CYP11B1CCR1CCR8CCR5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT TORAY INDUSTRIES, INC (JP) 2018-01-18 — — US disclosed
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT TORAY INDUSTRIES, INC (JP) 2018-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT SUN2, PAH, FARS2 CYP11B1 1041/4885CCR1 4606/4885CCR8 4289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback